BRIEF-Bayer AG Says Xarelto Plus Aspirin Significantly Lowered Combined Risk Of Limb Ischemia And Major Cardiovascular Events In Patients With Symptomatic Peripheral Artery Disease Post Revascularization - Reuters
[unable to retrieve full-text content] Emerging biomarkers and frontier therapies: unveiling the role of endothelial dysfunction in cerebral small vessel disease Frontiers
Comments
Post a Comment